Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cance — Dako Denmark A/S (PMA P100024)
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cance — Dako Denmark A/S (PMA P100024) is one of 9,000 device clearances in the DeviceClear dataset. Key details — Device name: Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cance; Applicant: Dako
| Device name | Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cance |
|---|---|
| Applicant | Dako Denmark A/S |
| Clearance track | PMA |
| Submission number | P100024 |
| Decision | OK30 |
| Decision date | 2015-09-10 |
| Date received | 2015-08-13 |
| Product code | NYQ |
| Device class | 3 |
| Medical specialty | Unknown |
| Applicant location | US |
| Source | openFDA device |
🔍 Search all device clearances →
$1999/mo
Try DeviceClear →